David Gillespie1, Carys Knapper2, Dyfrig Hughes3, Zoe Couzens4, Fiona Wood5, Marijn de Bruin6, Richard Ma7, Adam Thomas Jones8, Adam Williams9, Kerenza Hood9. 1. Centre for Trials Research, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, Wales gillespied1@cardiff.ac.uk. 2. Aneurin Bevan University Health Board, Newport, Wales. 3. Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, Wales. 4. Public Health Wales NHS Trust, Cardiff, UK. 5. Division of Population Medicine, Cardiff University, Cardiff, UK. 6. Radboud University Medical Center, Nijmegen, Netherlands. 7. Imperial College London, London, UK. 8. Policy, Research and International Development, Public Health Wales, Cardiff, UK. 9. Centre for Trials Research, School of Medicine, College of Biomedical & Life Sciences, Cardiff University, Cardiff, Wales.
The international community has adopted various measures to control the spread of SARS-CoV-2, the respiratory virus that causes COVID-19. The UK government introduced social distancing measures from 16 March 2020, to restrict journeys outdoors and limit physical proximity, including contacts with family and friends.1 2 Concurrently, necessity to redirect staff and resources to treat people hospitalised with COVID-19 has led to a suspension or alteration of other services across the National Health Service. In Wales, sexual healthcare has been impacted, limiting provision of HIV pre-exposure prophylaxis (PrEP).PrEP is prescribed to HIV-negative individuals who are at risk of acquiring HIV through risk behaviours (eg, condomless sexual intercourse) and prevents HIV by preventing viral replication following an exposure.3 It has been available across Wales through sexual health clinics since July 2017, with the latest reports indicating that 1200 individuals have received a prescription for PrEP across six health boards.4 5 The extent to which PrEP services have been affected by COVID-19 varies according to the number and timing of cases in different Health Boards.6 One PrEP clinic, located in a UK COVID-19 hotspot with over 50% of the COVID-19 cases in Wales (on 23 March 2020), initially paused delivery of PrEP services, with the exception of people at highest risk, for five weeks during the first peak of COVID-19 19 and has now recommenced services. Other centres are now providing up to six months’ supply of PrEP with or without HIV testing as available. All services are using remote consultations during the pandemic. Guidance on sexual contacts, in the context of social distancing and COVID-19, was issued by the British Association for Sexual Health and HIV on 26 March 2020 indicating that people should only have sexual contact with someone if they live within the same household.7This article aims to describe the early impact that COVID-19 and associated control measures on the sexual behaviour of PrEP users in Wales.
Methods
Data were obtained from an ongoing ecological momentary assessment study of individuals in receipt of HIV PrEP across four clinics in four of the six health boards in Wales offering PrEP and started recruitment in September 2019.8 9 The clinics and health boards were selected for inclusion in the study to capture a mixture of large and small clinics that were both geographically diverse and served urban and rural populations. Potentially eligible participants were approached to take part consecutively during PrEP clinic attendance, and recruited participants completed questionnaires at four time-points (aligning to PrEP clinic appointments). These questionnaires covered self-reported PrEP use, questions about sex and relationships, health behaviours and beliefs, symptoms commonly attributed to PrEP use and healthcare contacts. Online surveys were sent weekly to participants asking them to report episodes of condomless sexual intercourse during the preceding week. The cohort closed to recruitment on 27/01/2020 (n=60), and data are reported from 03/02/2020 until 10/05/2020. Two-level logistic regression models were fitted to self-reports of condomless sexual intercourse (yes/no, with repeated observations within participants and an unstructured covariance) and included time (week of completion) as a linear effect and an indicator for the introduction of social distancing measures (16/03/2020). The model was extended to explore differential associations between the introduction of social distancing measures and condomless sexual intercourse by relationship status (single/not single—interpreted as no regular/regular partner) and sexual health clinic (the clinic where PrEP services were largely paused was compared with other clinics). Results are reported as OR, associated 95% CIs. As our primary question relates to overall reports of condomless sexual intercourse following the introduction of social distancing measures, p values are reported for this finding only.
Results
Data were available from 56 participants (three participants provided no data and one withdrew prior to recruitment ending) covering a maximum of 784 person-weeks. Responses were obtained for 697 person-weeks (88.9%), with 358 person-weeks presocial distancing measures and 339 post. The number of participants responding within a given week ranged from 45 (week 13) to 52 (weeks 1, 6, 7 and 8). The median number of responses in a given week was 51 (IQR: 48–52). All participants were cis-gender male, 55 were white (98.2%), their median age was 36 years (IQR: 28–47 years) and 55 had sex exclusively with other men (98.2%). At the beginning of the observed period, 42 of the 56 participants had their relationship status categorised as single (75.0%).On average, 42.4% of participants reported condomless sexual intercourse in the period prior to the introduction of social distancing measures compared with 19.5% after (OR=0.16, 95% CI: 0.07 to 0.37, p<0.001). There was evidence to suggest that this association was moderated by relationship status (pre/postsocial distancing measure condomless sexual intercourse for those single: 42% to 13%; for those not single: 45% to 37%, OR single participant=0.09, 95% CI 0.06 to 0.23; OR for not single participant=0.46, 95% CI 0.16 to 1.25, figure 1). There was no evidence to suggest that changes in condomless sexual intercourse following social distancing measures were moderated by sexual health clinic (OR for interaction=0.70, 95% CI 0.29 to 1.70).
Figure 1
Predicted probabilities of condomless sexual intercourse (in the previous week) over time following the introduction of social distancing measures and the alteration of PrEP services in Wales. PrEP, pre-exposure prophylaxis.
Predicted probabilities of condomless sexual intercourse (in the previous week) over time following the introduction of social distancing measures and the alteration of PrEP services in Wales. PrEP, pre-exposure prophylaxis.
Conclusion
The introduction of social distancing measures and changes to PrEP services across Wales was associated with a marked reduction in reported instances of condomless sexual intercourse among respondents, with a larger reduction in those who were single (and therefore unlikely to have a regular partner) compared with those who were not.The study uses an ecological momentary assessment approach, whereby within-person changes can be measured and modelled over time. Furthermore, the study was set up prior to the COVID-19 pandemic and introduction of social distancing measures. While self-report condom use may generally be subject to social desirability bias, the step change observed following the introduction of social distancing measures was unlikely to induce an immediate shift in reporting bias.This cohort study included approximately 5% of all PrEP users in Wales and covered four of the six health boards in which PrEP is available via the NHS. Study participants were consecutively recruited from sexual health clinics and broadly representative of individuals accessing PrEP through the NHS in Wales (primarily white men who have sex with men (MSM)). While the median age of the cohort (36 years) was slightly higher than all NHS PrEP users in Wales (31), there was no evidence to suggest that age was associated with differential reports of condomless sexual intercourse preintroduction and postintroduction of social distancing measures.However, the use of a binary reports of condomless sexual intercourse may mask changes in other sexual behaviours (eg, sex with a condom, changes in number of sexual partners). This requires further exploration. The study benefitted from high levels of complete data. However, some biases may have been induced if those not responding to the online sexual behaviour survey were more or less likely to report condomless sexual intercourse than those who did respond. The study included primarily white MSM, and while this is largely representative of individuals accessing PrEP through the NHS in Wales, caution is urged when extrapolation these findings to other key populations. Finally, while relationship status was treated as a time-varying variable, reported changes in relationship status were too few to decompose these effects with-individuals and between-individuals. Furthermore, relationship status was not reported as regularly as sexual behaviour, and unmeasured changes in relationship status may explain some reports of condomless sexual intercourse among participants categorised as single and vice versa.This work provides added weight to calls from sexual health experts to use these control measures as an opportunity to mass test and treat at-risk populations for HIV and other STIs, in order to eliminate them from sexual networks.10 Furthermore, this analysis indicates a substantial shift in sexual behaviour since the introduction of social distancing measures, and the long-term impact of COVID-19 and associated control measures on this population’s physical and mental health and well-being requires close examination.
Authors: Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden Journal: N Engl J Med Date: 2010-11-23 Impact factor: 91.245
Authors: Amy Corneli; Brian Perry; Jamilah Taylor; Jeremy Beckford; Nneka Molokwu; Susan Reif; Johnny Wilson; Chelsea Gulden; Jacquelyn Bickham; Julia Siren; Wesley Thompson; Meredith E Clement Journal: AIDS Educ Prev Date: 2022-04
Authors: Ke Chun Zhang; Yuan Fang; He Cao; Hongbiao Chen; Tian Hu; Ya Qi Chen; Xiaofeng Zhou; Zixin Wang Journal: JMIR Public Health Surveill Date: 2022-05-25
Authors: Emily Dema; Jo Gibbs; Soazig Clifton; Andrew J Copas; Clare Tanton; Julie Riddell; Raquel Bosó Pérez; David Reid; Chris Bonell; Magnus Unemo; Catherine H Mercer; Kirstin R Mitchell; Pam Sonnenberg; Nigel Field Journal: Lancet Public Health Date: 2022-01
Authors: Katariina Saarentausta; Lovisa Ivarsson; Susanne Jacobsson; Björn Herrmann; Martin Sundqvist; Magnus Unemo Journal: APMIS Date: 2021-11-25 Impact factor: 3.428
Authors: Thibaut Vanbaelen; Anke Rotsaert; Bart K M Jacobs; Eric Florence; Chris Kenyon; Bea Vuylsteke; Marie Laga; Reyniers Thijs Journal: AIDS Patient Care STDS Date: 2022-04 Impact factor: 5.944
Authors: Lara K Marquez; Patrick Ingiliz; Christoph Boesecke; Ivanka Krznaric; Knud Schewe; Thomas Lutz; Stefan Mauss; Stefan Christensen; Jürgen K Rockstroh; Sonia Jain; Feng He; Joel O Wertheim; Natasha K Martin Journal: PLoS One Date: 2022-05-12 Impact factor: 3.752
Authors: M Uhrmacher; A Skaletz-Rorowski; S Nambiar; A J Schmidt; P Ahaus; K Serova; I Mordhorst; A Kayser; J Wach; C Tiemann; D Münstermann; N H Brockmeyer; A Potthoff Journal: Front Public Health Date: 2022-08-24